Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020

Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020–present)

Published:2022-12-02 Issue:12 Volume:32 Page:1175-1184
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Shi Xiaoyu¹,Zhao Tong¹,da Silva-Júnior Edeildo Ferreira²,Zhang Jian¹,Xu Shujing¹,Gao Shenghua¹,Liu Xinyong¹,Zhan Peng¹

Affiliation:

1. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Shandong, PR China

2. Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceió, Alagoas, Brazil

Funder

funded

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2022.2165911

Reference69 articles.

1. Gout

2. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease

3. Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms

4. The biology of urate

5. Phylogenetic Articulation of Uric Acid Evolution in Mammals and How It Informs a Therapeutic Uricase

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protecting against ferroptosis in hyperuricemic nephropathy: The potential of ferrostatin-1 and its inhibitory effect on URAT1;European Journal of Pharmacology;2024-05

2. Priestia megaterium ASC-1 Isolated from Pickled Cabbage Ameliorates Hyperuricemia by Degrading Uric Acid in Rats;Microorganisms;2024-04-20

3. Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities;European Journal of Medicinal Chemistry;2024-04

4. Uric acid in health and disease: From physiological functions to pathogenic mechanisms;Pharmacology & Therapeutics;2024-04

5. Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability;Journal of Medicinal Chemistry;2024-03-14